Core Scientific, Inc. (CORZ) has been upgraded to a Zacks Rank #2 (Buy), indicating a significant upward trend in its earnings estimates. The Zacks Consensus Estimate for CORZ has notably increased by 371.4% over the past three months, reflecting an improved earnings outlook. This upgrade, which places CORZ in the top 20% of Zacks-covered stocks based on estimate revisions, suggests potential for near-term stock price appreciation.
Core Scientific, Inc. (CORZ) has received a significant upgrade to a Zacks Rank #2 (Buy), a designation driven entirely by positive momentum in its earnings outlook. The primary catalyst for this change is a substantial 371.4% increase in the Zacks Consensus Estimate over the past three months, signaling a sharply improved perception of the company's underlying business fundamentals among sell-side analysts. According to the report, this places CORZ in the top 20% of stocks covered by the Zacks system in terms of estimate revisions, a factor strongly correlated with near-term price movements due to its influence on institutional valuation models. However, it is noted that the current consensus estimate for the fiscal year ending December 2025 is $1.29 per share, which represents no year-over-year change, suggesting the dramatic upward revisions may be concentrated in a prior or current period rather than indicating sustained future growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment